← Back to headlines
Guggenheim Raises Eli Lilly (LLY) Price Target Amid Acquisitions
Guggenheim has increased its price target for Eli Lilly (LLY), attributing the adjustment to the pharmaceutical company's recent series of acquisition deals.
29 Apr, 16:03 — 29 Apr, 16:03
Sources
Showing 1 of 1 sources
